CYPB Insider Trading Activity and SEC Form 4 Filings
CYPB insider trading summary
No open-market insider purchases or sales of Cypress Bioscience Inc (CYPB) have been reported on SEC Form 4 in the past 12 months.
Latest CYPB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 28, 2010 | Jay D Kranzler | CEO | Sell | $162K (25,000 @ $6.46) |
| Dec 23, 2010 | Jay D Kranzler | CEO | Sell | $983K (152,464 @ $6.45) |
| Dec 20, 2010 | Rao Srinivas | Chief Scientific Officer | Sell | $48K (7,500 @ $6.44) |
| Jul 15, 2010 | R Michael Gendreau | Chief Medical Officer | Buy | $21K (10,000 @ $2.13) |
| Jul 8, 2010 | R Michael Gendreau | Chief Medical Officer | Buy | $11K (5,000 @ $2.21) |
| Nov 9, 2009 | Michael Walsh | Exec VP & CCO | Buy | $30K (5,000 @ $6.00) |
| Aug 3, 2009 | Jay D Kranzler | CEO | Sell | $652K (75,000 @ $8.69) |
| Jul 6, 2009 | Jay D Kranzler | CEO | Sell | $653K (75,000 @ $8.70) |
| Mar 2, 2009 | Jay D Kranzler | CEO | Sell | $614K (75,000 @ $8.19) |
| Feb 2, 2009 | Jay D Kranzler | CEO | Sell | $9K (1,000 @ $8.53) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.